These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1815968)

  • 1. The effect of food or milk on the absorption kinetics of ofloxacin.
    Dudley MN; Marchbanks CR; Flor SC; Beals B
    Eur J Clin Pharmacol; 1991; 41(6):569-71. PubMed ID: 1815968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milk and yoghurt do not impair the absorption of ofloxacin.
    Neuvonen PJ; Kivistö KT
    Br J Clin Pharmacol; 1992 Mar; 33(3):346-8. PubMed ID: 1576061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of single rising doses of ofloxacin in healthy volunteers.
    Marchbanks CR; Dudley MN; Flor S; Beals B
    Pharmacotherapy; 1992; 12(1):45-9. PubMed ID: 1549538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin.
    Mueller BA; Brierton DG; Abel SR; Bowman L
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2101-5. PubMed ID: 7811026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of absorption and elimination of ofloxacin in humans after oral and rectal administrations.
    Eboka CJ; Okor RS; Akerele JO; Aigbavboa SO
    J Clin Pharm Ther; 1997 Jun; 22(3):217-20. PubMed ID: 9447477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers.
    Hasegawa T; Yamaki K; Nadai M; Muraoka I; Wang L; Takagi K; Nabeshima T
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):57-61. PubMed ID: 8004359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ofloxacin. An overview.
    Flor S
    Am J Med; 1989 Dec; 87(6C):24S-30S. PubMed ID: 2603892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence study of a fixed dose combination of nitazoxanide and ofloxacin in Indian healthy volunteers.
    Agarwal S; Solomon WD; Gowda KV; Selvan PS; Ghosh D; Sarkar AK; Chattaraj TK; Pal TK
    Arzneimittelforschung; 2007; 57(10):679-83. PubMed ID: 18074762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption characteristics of a new valproate formulation: divalproex sodium-coated particles in capsules (Depakote Sprinkle).
    Carrigan PJ; Brinker DR; Cavanaugh JH; Lamm JE; Cloyd JC
    J Clin Pharmacol; 1990 Aug; 30(8):743-7. PubMed ID: 2119396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers.
    Guay D; Tack K; Flor S
    Int J Clin Pharmacol Res; 1991; 11(5):203-9. PubMed ID: 1814841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion of ofloxacin into saliva in patients with respiratory tract infection.
    Takagi K; Hasegawa T; Yamaki K; Suzuki K; Nabeshima T
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):46-50. PubMed ID: 1551745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of oral ofloxacin after cytotoxic chemotherapy for haematological malignancy.
    Brown NM; White LO; Blundell EL; Chown SR; Slade RR; MacGowan AP; Reeves DS
    J Antimicrob Chemother; 1993 Jul; 32(1):117-22. PubMed ID: 8226402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of food or milk on the bioavailability of etintidine in healthy subjects.
    Huang SM; Marriott TB; Weintraub HS; Boccagno JA; Abels R
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):113-7. PubMed ID: 2900817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis.
    Orlando R; Sawadogo A; Miglioli PA; Cappellazzo MG; Palatini P
    Chemotherapy; 1992; 38(1):1-6. PubMed ID: 1617997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the influence of Ca2+ on absorption parameters of ciprofloxacin and ofloxacin.
    Sánchez Navarro A; Martínez Cabarga M; Dominguez-Gil Hurlé A
    J Antimicrob Chemother; 1994 Jul; 34(1):119-25. PubMed ID: 7961198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC-MS/MS.
    Li J; Zhao H; Okeke CI; Li L; Liu Z; Yin Z; Zhuang P; Sun J; Wu T; Wang M; Li N; Pi J; Zhang Q; Zhang R; Ma L; Pang X; Liu Z; Zhang L; Fan L
    Int J Pharm; 2013 Jun; 450(1-2):104-13. PubMed ID: 23612359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers.
    Yuk JH; Nightingale CH; Quintiliani R; Sweeney KR
    Antimicrob Agents Chemother; 1991 Feb; 35(2):384-6. PubMed ID: 2024973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of food on the interaction of ofloxacin with sucralfate in healthy volunteers.
    Kawakami J; Matsuse T; Kotaki H; Seino T; Fukuchi Y; Orimo H; Sawada Y; Iga T
    Eur J Clin Pharmacol; 1994; 47(1):67-9. PubMed ID: 7988627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.